No abstract available
MeSH terms
-
Animals
-
Apoptosis / drug effects
-
Becaplermin
-
Benzamides / pharmacology*
-
Benzamides / therapeutic use*
-
Cell Proliferation / drug effects
-
Clinical Trials as Topic
-
Female
-
Gene Expression / drug effects
-
Humans
-
Hypertension, Pulmonary / drug therapy*
-
Hypertension, Pulmonary / genetics*
-
Imatinib Mesylate
-
Male
-
Middle Aged
-
Molecular Targeted Therapy*
-
Muscle, Smooth, Vascular / cytology
-
Muscle, Smooth, Vascular / drug effects
-
Piperazines / pharmacology*
-
Piperazines / therapeutic use*
-
Protein Kinase Inhibitors / pharmacology*
-
Protein Kinase Inhibitors / therapeutic use*
-
Proto-Oncogene Proteins c-sis / genetics
-
Proto-Oncogene Proteins c-sis / physiology
-
Pulmonary Artery / drug effects
-
Pulmonary Veno-Occlusive Disease / drug therapy
-
Pyrimidines / pharmacology*
-
Pyrimidines / therapeutic use*
-
Receptors, Platelet-Derived Growth Factor / antagonists & inhibitors
-
Vasoconstriction / drug effects
Substances
-
Benzamides
-
Piperazines
-
Protein Kinase Inhibitors
-
Proto-Oncogene Proteins c-sis
-
Pyrimidines
-
Becaplermin
-
Imatinib Mesylate
-
PDGF receptor tyrosine kinase
-
Receptors, Platelet-Derived Growth Factor